4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001209191-13-036095
CIK 0001333170operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:11 PM ET
Size
8.7 KB
Accession
0001209191-13-036095
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Sale
Common Stock
2013-07-08$14.34/sh−7,000$100,380→ 13,071 total - Exercise/Conversion
Common Stock
2013-07-08$4.32/sh+5,000$21,600→ 20,071 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-08−5,000→ 80,000 totalExercise: $4.32From: 2009-03-31Exp: 2015-03-30→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
- [F2]This stock option vests as to 25% of the underlying shares on March 31, 2009 and then in 36 equal monthly installments thereafter.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:11 PM ET
- Size
- 8.7 KB